BeStock  
Stocks › Biotechnology › ANL

Adlai Nortye Group ANL

US equityMarket cap rank #3538Biotechnology
$8.55 −$0.51 (-5.63%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.55 0.00%
Open$8.93
Prev close$9.06
Day range$8.36 – $9.11
Volume380.6K
Market cap$550.60M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-16.1x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average -4.1x

Price / book3.2x
CheapRich

Near the top of its 5-year range · 84th percentile, 5-year average -3.3x

#3839 of 5329 stocks by PB (1 = cheapest)

Price / sales37.8x
CheapRich

Above its usual level · 73rd percentile, 5-year average 36.2x

#4840 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-26x-16x-7x3xAug '23Mar '25Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$16.25
Price vs. fair value-47.4%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.18 – -3.27 84% (pricier than usual) #3839 of 5329 (1 = cheapest)
PE -16.08 -23.65 -4.06 3% (cheaper than usual) –
PS 37.84 55.03 36.22 73% (pricier than usual) #4840 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ANL.

Sign in to join the discussion.

Scroll to Top